» Articles » PMID: 12783345

Endoscopic Palliation of Malignant Gastric Outlet Obstruction Using Self-expandable Metallic Stents: Results of a Multicenter Study

Overview
Journal Endoscopy
Date 2003 Jun 5
PMID 12783345
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Study Aims: Gastric outlet obstruction is a late event in the natural history of biliopancreatic tumours. Metallic self-expanding stents inserted under endoscopic and fluoroscopic guidance can be used for palliation. The aim of this study was to evaluate the feasibility, efficacy, and complications of endoscopic duodenal stenting in patients with malignant gastric outlet obstruction.

Patients And Methods: Between August 1998 and November 2001, 63 patients (31 women, 32 men; mean age 73 +/- 12) presenting with clinical symptoms of duodenal obstruction underwent endoscopic stenting with large metallic prostheses. Complications and clinical outcome were assessed both retrospectively and prospectively.

Results: Of the patients, 58 needed one duodenal stent and two overlapping stents were required in five patients. Stenting was immediately successful in 60/63 patients (95%). At the time of the duodenal procedure, 25 previously inserted biliary stents were still patent; biliary stenting was attempted during the same procedure in 18 patients; and 20 patients had no biliary stricture. There was no procedure-related mortality. There were complications in 30 % of patients: 13 stent obstructions, 4 stent migrations and 2 duodenal perforations (treated surgically). For 44 patients (70%) there were no minor or major digestive problem during their remaining lifetime. An exclusively peroral diet was possible in 58 patients (92%), but was considered satisfactory (solid or soft) in 46/63 patients (73%). Of the patients, 53 (84 %) died between 1 and 64 weeks after the duodenal stenting (median survival 7 weeks).

Conclusions: Endoscopic stenting for the palliation of malignant gastric outlet obstruction is feasible and well-tolerated in most patients. Most dysfunctions can be managed endoscopically.

Citing Articles

A Meta-Analysis of Endoscopic Stenting Versus Surgical Treatment for Malignant Gastric Outlet Obstruction.

Del Nero L, Sheijani A, De Ceglie A, Bruzzone M, Ceppi M, Filiberti R World J Surg. 2023; 47(6):1519-1529.

PMID: 36869171 DOI: 10.1007/s00268-023-06944-3.


Technical and clinical success rates of WallFlex duodenal stents in unresectable malignant gastric outlet obstruction. A retrospective observational study from a tertiary cancer hospital in India.

Raina H, Patil P, Mehta S Prz Gastroenterol. 2022; 17(1):41-46.

PMID: 35371362 PMC: 8942001. DOI: 10.5114/pg.2022.114596.


Palliative Surgery or Metallic Stent Positioning for Advanced Gastric Cancer: Differences in QOL.

Fiori E, Crocetti D, Sapienza P, Cirocchi R, Sterpetti A, Miccini M Medicina (Kaunas). 2021; 57(5).

PMID: 33925171 PMC: 8146574. DOI: 10.3390/medicina57050428.


Upper gastrointestinal stenting during the SARS-CoV-2 outbreak: impact of mitigation measures and risk of contamination for patients and staff.

Rodrigues-Pinto E, Ferreira-Silva J, Fugazza A, Capogreco A, Repici A, Everett S Endosc Int Open. 2021; 9(1):E76-E86.

PMID: 33403239 PMC: 7775809. DOI: 10.1055/a-1319-1201.


Clinical outcomes after multiple self-expandable metallic stent placement using stent-in-stent technique for malignant gastric outlet obstruction.

Mo J, Kim Y, Kim J, Shin S, Youn Y, Park H Medicine (Baltimore). 2020; 99(21):e19432.

PMID: 32481247 PMC: 7249911. DOI: 10.1097/MD.0000000000019432.